Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Moberg Pharma Sells OTC Business - Happi
Company News

Moberg Pharma Sells OTC Business

US-based unit includes drug store treatments like Dermoplast, New Skin and Kersal.

Moberg Pharma, Stockholm, has entered into an agreement with RoundTable Healthcare Partners and Signet Healthcare Partners to divest its entire North American OTC operation in deal that includes a cash consideration of $155 million plus an additional consideration of $5 million. Moberg Pharma North American LLC, based in Cedar Knolls, NJ, sells drug store staples such as Kerasal nail and foot care products, Dermoplast  topical pain relief products and New Skin liquid bandages.
 
RoundTable Healthcare Partners and Signet Healthcare Partners to divest its entire North American OTC operation in deal that includes a cash consideration of $155 million plus an additional consideration of $5 million. Moberg Pharma North American LLC, based in Cedar Knolls, NJ, sells drug store staples such as Kerasal nail and foot care products, Dermoplast  topical pain relief products and New Skin liquid bandages.
 
In the most recent fiscal year, Kerasal Nail recorded its third consecutive year of double-digit growth in the US and in 2018 became ranked as the  No. individual product in the nail fungus segment as well as in the entire foot care category, according to Moberg.
 
According to Moberg, the OTC-business generated sales of SEK 434 million (approximately $46.7 million dollars) in 2018.
 
The sale of the OTC unit will provide funding for development and commercialization of a product in Moberg’s pipeline called MOB-015, which the firm also announced it will commercialize with Bayer AG through a licensing deal.
 
RoundTable Healthcare Partners’ portfolio includes physician-dispensed Revision Skincare and Goodier Cosmetics.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters